SPONSOR
AHS Cancer Control Alberta
Total Trials
4
Recruiting
4
Phases
Phase 2, Phase 3, Phase 1, Phase 2
Conditions studied: Metastatic Non Small Cell Lung CancerGynecologic CancerAnemiaIron-deficiencyColorectal CancerLiver Metastasis Colon CancerCancer
AHS Cancer Control Alberta is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Metastatic Non Small Cell Lung Cancer, Gynecologic Cancer, Anemia, Iron-deficiency.
The trial portfolio spans Phase 2, Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — AHS Cancer Control Alberta
How many clinical trials has AHS Cancer Control Alberta sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by AHS Cancer Control Alberta, of which 4 are actively recruiting participants. These trials cover conditions including Metastatic Non Small Cell Lung Cancer, Gynecologic Cancer, Anemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does AHS Cancer Control Alberta research focus on?
AHS Cancer Control Alberta clinical trials span Metastatic Non Small Cell Lung Cancer, Gynecologic Cancer, Anemia, Iron-deficiency, Colorectal Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a AHS Cancer Control Alberta clinical trial?
To participate in a AHS Cancer Control Alberta trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all AHS Cancer Control Alberta trials with current recruitment status updated daily.
Clinical Trials by AHS Cancer Control Alberta
NCT06882174 Phase 2
Recruiting
This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer
NCT05407987 Phase 3
Recruiting
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
Gynecologic Cancer
NCT05775146 Phase 2
Recruiting
SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases
Colorectal Cancer
NCT05413473 Phase 1, Phase 2
Recruiting
Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)
Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology